Fingerprint
Dive into the research topics of 'Belimumab in the treatment of systemic lupus erythematosus: High disease activity predictors of response'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Belimumab in the treatment of systemic lupus erythematosus: High disease activity predictors of response
Ronald F. Van Vollenhoven, Michelle A. Petri, Ricard Cervera, David A. Roth, Beulah N. Ji, Christi S. Kleoudis, Z. John Zhong, William Freimuth
Research output: Contribution to journal › Article › peer-review
240
Scopus
citations